A hub and spoke community model to equitably deliver regenerative medicine therapies to diverse populations across four California counties

  • Post author:
  • Post category:

Expand capacities to deliver novel cell and gene therapy treatments to diverse communities across four California Counties (REAL: ORange, RivErside, San BernArdino, and Los Angeles). We will conduct regenerative medicine…

Continue ReadingA hub and spoke community model to equitably deliver regenerative medicine therapies to diverse populations across four California counties

The City of Hope Alpha Clinic: A roadmap for equitable and inclusive access to regenerative medicine therapies for all Californians

  • Post author:
  • Post category:

City of Hope has long developed groundbreaking therapies, and building on that success we want to democratize cancer care by bringing therapies to patients rather than making them come to…

Continue ReadingThe City of Hope Alpha Clinic: A roadmap for equitable and inclusive access to regenerative medicine therapies for all Californians

A comprehensive stem cell and gene therapy clinic to advance new therapies for a diverse patient population in California

  • Post author:
  • Post category:

We aim to markedly expand access of all Californians to outstanding cell and gene therapy trials for multiple conditions with unmet treatment needs. We will also contribute with excellence to…

Continue ReadingA comprehensive stem cell and gene therapy clinic to advance new therapies for a diverse patient population in California

A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus

  • Post author:
  • Post category:

Therapeutic Candidate or Device IMPT-514 is an autologous T-cell product genetically modified to express a chimeric antigen receptor targeting CD19 and CD20 Indication Active, refractory lupus nephritis (LN) and systemic…

Continue ReadingA phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus